OGFOD3
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3
Also known as: C17orf101, FLJ22222, OGFD3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PK18
- Gene
- OGFOD3
- Ensembl
- ENSG00000181396
- Chromosome
- 17
- Canonical length
- 319 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable several functions, including L-ascorbic acid binding activity; dioxygenase activity; and iron ion binding activity. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
319 residues, UniProt reviewed canonical sequence.
>Q6PK18|OGFOD3
1 MAPQRRAATK APEGNGAAER RNRSSTKKDR APREVQRLWQ RPWLRTAGLG AGFVLTALLL
61 WSSLGADDGV AEVLARRGEV VAGRFIEVPC SEDYDSHRRF EGCTPRKCGR GVTDVVITRE
121 EAERIRSVAE KGLSLGGSDG GASILDLHSG ALSVGKHFVN LYRYFGDKIQ NIFSEEDFRL
181 YREVRQKVQL TIAEAFGISA SSLHLTKPTF FSRINSTEAR TAHDEYWHAH VDKVTYGSFD
241 YTSLLYLSNY LEDFGGGRFM FMEEGANKTV EPRAGRVSFF TSGSENLHRV EKVHWGTRYA
301 ITIAFSCNPD HGIEDPAFPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OGFOD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 26 nTPM
- pancreas: 24 nTPM
- skeletal muscle: 23 nTPM
- heart muscle: 23 nTPM
- pituitary gland: 21 nTPM
- liver: 20 nTPM
Single-cell type
- extravillous trophoblasts: 81 nCPM
- late spermatids: 71 nCPM
- epididymal principal cells: 58 nCPM
- decidual stromal cells: 58 nCPM
- oocytes: 55 nCPM
- pancreatic islet cells: 55 nCPM
Immune cell
- myeloid DC: 24 nTPM
- classical monocyte: 14 nTPM
- memory B-cell: 14 nTPM
- memory CD8 T-cell: 13 nTPM
- intermediate monocyte: 13 nTPM
- plasmacytoid DC: 12 nTPM
Brain region
- choroid plexus: 26 nTPM
- cerebellum: 18 nTPM
- medulla oblongata: 17 nTPM
- cerebral cortex: 16 nTPM
- white matter: 16 nTPM
- pons: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
- dioxygenase activity
- iron ion binding
- L-ascorbic acid binding
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Oxoglutarate/iron-dependent dioxygenase domain
- Prolyl 4-hydroxylase, alpha subunit
- Prolyl 4-hydroxylase alpha subunit, Fe(2+) 2OG dioxygenase domain
- 2OG-Fe(II) oxygenase superfamily
- 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OGFOD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OGFOD3 as an antibody target. Whether an autoantibody or antibody against OGFOD3 could matter depends on whether native OGFOD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OGFOD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OGFOD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...